Try our Advanced Search for more refined results

In Re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation

  1. August 04, 2015

    Philly Court Proves Its Mettle Crafting Nationwide Yaz Deal

    A Pennsylvania state judge's key role shepherding an overnight negotiation that resulted in Monday's nearly $60 million nationwide settlement ending claims against Bayer Corp. over alleged heart attacks and strokes caused by Yaz, Yasmin and Ocella birth control pills highlights the Philadelphia County court's prowess in handling complex mass tort litigation.

  2. February 13, 2015

    Bayer Chided As Yaz Blood Clot MDL Case Gets Trial Date

    An Illinois federal judge overseeing the multidistrict litigation over the alleged stroke risks of Bayer HealthCare Pharmaceuticals Inc.'s birth control drug Yaz on Friday set a June trial date for one of the suits in the litigation, remarking that Bayer's strategy in the litigation amounted to "wearing everyone down over time."

  3. March 19, 2013

    Bayer Pays $24M To Settle Yaz, Yasmin Gallbladder Cases

    A federal judge gave approval to Bayer HealthCare Pharmaceuticals Inc.'s settlement to pay $24 million to patients claiming they developed gallbladder disease or had their gallbladders removed after using Bayer's Yaz and Yasmin birth control pills, according to an agreement filed in multidistrict litigation court last week.

  4. January 11, 2012

    FDA Advisers On Yaz Had Ties To Bayer: Ex-Agency Chief

    Some U.S. Food and Drug Administration advisers who voted that Bayer AG's Yasmin, Yaz and other birth control pills were more beneficial than harmful had improper ties to the drugmaker, an ex-FDA chief asserted in testimony unsealed last week in an Illinois federal court overseeing multidistrict litigation.

  5. January 03, 2012

    Judge Scraps First Bellwether Trial In Yaz MDL

    An Illinois federal judge on Saturday abandoned a plan to hold on Jan. 9 the first bellwether trial in multidistrict litigation accusing Bayer Corp. of hiding health risks posed by birth control pills Yaz and Yasmin, and appointed a mediator instead.

  6. December 05, 2011

    Bayer Covered Up Yasmin Blood Clot Risk: Ex-FDA Head

    Bayer AG hid the significance of potentially serious side effects of its Yasmin contraceptives despite knowing they were more likely to cause blood clots than other oral contraceptives, according to a former U.S. Food and Drug Administration chief's report unsealed Monday in multidistrict litigation in Illinois.

  7. October 27, 2011

    Yaz MDL Plaintiffs Say FDA Should See Confidential Docs

    The plaintiffs' steering committee in multidistrict litigation over Bayer Corp. birth control pills Yaz and Yasmin asked an Illinois federal judge Thursday for authority to present the U.S. Food and Drug Administration with confidential documents about the health risks of pills containing drospirenone.

  8. May 05, 2011

    Yaz Consumers Fail To Win Class Cert. In MDL Case

    The Illinois federal judge overseeing a multidistrict litigation over Bayer Corp. birth control pill Yaz on Wednesday refused to certify a nationwide class of individuals allegedly harmed by the contraceptive.

  9. October 15, 2009

    Schlichter Hits Back In Yaz MDL Counsel Fray

    The law firm Schlichter Bogard & Denton LLP fired back Thursday at claims it rushed to step in as interim plaintiffs counsel in a multidistrict ligation accusing Bayer of misleading women about alleged dangers of taking the Yaz and Yasmin oral contraceptives.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!